allogeneic stem cell transplantation (alloSCT)
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
... of allogeneic stem cell transplantation (alloSCT), a retrospective, registry-based comparison was performed, including 11,439 patients with de novo and 1325 with ...
10
Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT
... first allogeneic stem cell transplantation in all patients (95% confidence intervals were showed as dashed lines) (A) and in recipients of liver (solid line) and kidney (dashed line) grafts ...
10
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
... Conclusions: The data demonstrate in the largest retrospective cohort of non-cutaneous PTCL so far reported that alloSCT after RIC or MAC is an effective strategy, even in chemoresistant patients. Keywords: ...
13
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
... Conclusions: The data demonstrate in the largest retrospective cohort of non-cutaneous PTCL so far reported that alloSCT after RIC or MAC is an effective strategy, even in chemoresistant patients. Keywords: ...
12
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT
... (RIC) allogeneic stem cell transplantation into the mainstay of clinical management of older patients with acute lymphoblastic leukemia (ALL) more than a decade ago [1] represented a ...
8
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.
... lymphocyte-depleted allogeneic bone marrow transplantation by pre- emptive donor leukocyte ...T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte ...
21
Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome : a study from the French Society of Bone Marrow Transplantation and Cellular Therapy
... Marrow Transplantation. INTRODUCTION Allogeneic hematopoietic stem cell transplantation (allo- SCT) remains the only potentially curative therapeutic approach in patients with ...
9
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
... autologous stem cell transplantation (ASCT) is a rare complica- tion with no curative ...option. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be ...
9
Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.
... This is notably true when evaluating non-myeloablative or reduced-intensity conditioning (RIC) regimens before allogeneic stem cell transplantation (Allo-SCT). RIC Allo-SCT has emerged in the ...
11
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma
... Renal cell carcinoma (RCC) is particularly sensitive to immune ...hematopoietic stem cell transplantation (HSCT), in particular the 14 bp insertion/deletion polymorphism in the 3 ′ ...
6
Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.
... after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571 Donor lymphocyte infusion (DLI) has become standard therapy for relapse after ...
2
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial
... We prospectively evaluated the safety and efficacy of a clofarabine, intravenous busulfan and antithymocyte glob- ulin-based reduced-toxicity conditioning (CloB2A2) regimen before allogeneic stem ...
7
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia : a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
... which allogeneic stem cell transplantation (allo-SCT) remains the only potentially curative ...Conclusions: Allogeneic stem cell transplantation is a valid ...
10
View of Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation
... · Allogeneic hematopoietic stem cell transplantation Introduction L ’allogreffe de cellules souches hématopoïétiques (ACSH) constitue un traitement curatif de différentes pathologies ...
8
Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma
... after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma, Acta Clinica Belgica, 71:6, 428-430, DOI: ...
4
Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature
... Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treat- ment option in both adult and pediatric patients with malignant and non-malignant hemato- logical ...
10
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)
... that allogeneic hematopoietic stem cell transplantation (HSCT) might possibly serve to consolidate the response to initial ...for stem cell transplantation ...
5
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy
... Haematopoietic stem cell transplantation has been proposed as treatment for mitochondrial neurogastrointestinal encephalomyo- pathy, a rare fatal autosomal recessive disease due to TYMP mutations ...
12
Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation
... a b s t r a c t The rapidly increasing use of allogeneic stem cell transplantation (allo-SCT) emphasizes the need for iden- tifying variables predictive of its outcome. Plasmacytoid dendritic ...
7
Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
... of allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...and cell surface recognition molecules by host cells and thereby enhancing the recognition of host minor or major ...
9